These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 7726487)
1. Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics. Bradford PA; Sanders CC Antimicrob Agents Chemother; 1995 Feb; 39(2):308-13. PubMed ID: 7726487 [TBL] [Abstract][Full Text] [Related]
2. The Importance of Porins and β-Lactamase in Outer Membrane Vesicles on the Hydrolysis of β-Lactam Antibiotics. Kim SW; Lee JS; Park SB; Lee AR; Jung JW; Chun JH; Lazarte JMS; Kim J; Seo JS; Kim JH; Song JW; Ha MW; Thompson KD; Lee CR; Jung M; Jung TS Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316670 [TBL] [Abstract][Full Text] [Related]
3. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases. Jacoby GA; Carreras I Antimicrob Agents Chemother; 1990 May; 34(5):858-62. PubMed ID: 2193623 [TBL] [Abstract][Full Text] [Related]
4. Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli. Hiraoka M; Okamoto R; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1989 Mar; 33(3):382-6. PubMed ID: 2658786 [TBL] [Abstract][Full Text] [Related]
5. Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae. Werner V; Sanders CC; Sanders WE; Goering RV Antimicrob Agents Chemother; 1985 Apr; 27(4):455-9. PubMed ID: 3873897 [TBL] [Abstract][Full Text] [Related]
6. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794 [TBL] [Abstract][Full Text] [Related]
8. Selection and characterization of beta-lactam-resistant Escherichia coli K-12 mutants. Jaffé A; Chabbert YA; Derlot E Antimicrob Agents Chemother; 1983 Apr; 23(4):622-5. PubMed ID: 6344786 [TBL] [Abstract][Full Text] [Related]
9. beta-Lactamases and beta-lactam resistance in Escherichia coli. Jacoby GA; Sutton L Antimicrob Agents Chemother; 1985 Nov; 28(5):703-5. PubMed ID: 3911882 [TBL] [Abstract][Full Text] [Related]
10. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams. Jaffe A; Chabbert YA; Semonin O Antimicrob Agents Chemother; 1982 Dec; 22(6):942-8. PubMed ID: 6760806 [TBL] [Abstract][Full Text] [Related]
11. Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa. Hancock RE; Woodruff WA Rev Infect Dis; 1988; 10(4):770-5. PubMed ID: 2460909 [TBL] [Abstract][Full Text] [Related]
12. beta-Lactamases and susceptibility to beta-lactam antibiotics in Escherichia coli. Wu PJ; Shannon K; Phillips I J Antimicrob Chemother; 1992 Dec; 30(6):868-71. PubMed ID: 1344881 [No Abstract] [Full Text] [Related]
13. Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains. Ripoll A; Galán JC; Rodríguez C; Tormo N; Gimeno C; Baquero F; Martínez-Martínez L; Cantón R; J Clin Microbiol; 2014 Jan; 52(1):122-9. PubMed ID: 24153133 [TBL] [Abstract][Full Text] [Related]
14. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles. Martínez-Martínez L; Conejo MC; Pascual A; Hernández-Allés S; Ballesta S; Ramírez De Arellano-Ramos E; Benedí VJ; Perea EJ Antimicrob Agents Chemother; 2000 Sep; 44(9):2534-6. PubMed ID: 10952609 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment. Nikaido H; Normark S Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755 [TBL] [Abstract][Full Text] [Related]
16. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation. Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019 [TBL] [Abstract][Full Text] [Related]
17. Impact of defined cell envelope mutations in Escherichia coli on the in vitro antibacterial activity of avibactam/β-lactam combinations. McLeod SM; Patey SA; Huband MD; Nichols WW Int J Antimicrob Agents; 2017 Apr; 49(4):437-442. PubMed ID: 28242258 [TBL] [Abstract][Full Text] [Related]
18. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases. Sougakoff W; Jarlier V J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618 [TBL] [Abstract][Full Text] [Related]
19. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'. Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439 [TBL] [Abstract][Full Text] [Related]
20. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics. Hrebenda J; Heleszko H J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]